News Results
There are 798,609 News Results
Sep 10, 2024
Pre-medication regimen showed an infusion-related reaction rate of 22.5 percent with intravenous RYBREVANT(®), a three-fold reduction from 67.4 percent historically seen with standard IRR management
Sep 14, 2024
Post-progression outcomes showed significant and sustained improvement for RYBREVANT(®) plus standard of care versus chemotherapy alone
Sep 19, 2024
Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking the third new indication for RYBREVANT(®) this year, with four indications overall
Oct 16, 2024
Woodside Energy Group (ASX: WDS) (NYSE: WDS) (LSE: WDS): Woodside CEO Meg O’Neill said: “We would like to acknowledge the tragic death in early October of an employee of one...
Oct 30, 2024
Hess Corporation (NYSE: HES) today reported net income of $498 million, or $1.62 per share, in the third quarter of 2024, compared with net income of $504 million, or $1.64...
Nov 15, 2024
Chemtrade Logistics Income Fund (TSX: CHE.UN) (“Chemtrade” or the “Fund”) today announced results for the three- and nine-month periods ended September 30, 2024. The financial statements and MD&A will be...
Dec 8, 2024
New analysis from Phase 3 CEPHEUS study demonstrates 85 percent of patients who achieved MRD negativity (10(-6)) with DARZALEX FASPRO
Jan 29, 2025
Hess Corporation (NYSE: HES) today reported net income of $542 million, or $1.76 per share, in the fourth quarter of 2024, compared with net income of $413 million, or $1.34...
Jan 30, 2025
L3Harris Technologies (NYSE: LHX) reported fourth quarter 2024 diluted EPS of $2.37 on fourth quarter 2024 revenue of $5.5 billion. Fourth quarter 2024 non-GAAP diluted EPS was $3.47. Fourth quarter...
Feb 20, 2025
HNI Corporation (NYSE: HNI) today announced net sales of $2.526 billion and net income of $139.5 million for the full year ended December 28, 2024. Fourth quarter net sales and...
